Outcomes of endoscopic optic nerve decompression in patients with idiopathic intracranial hypertension

• Published in: International forum of allergy & rhinology 2017-06, Vol.7 (6), p.615-623
• Main Authors: Tarrats, Luisam, Hernández, Gabriel, Busquets, José M., Portela, Juan C., Serrano, Luis A., González‐Sepúlveda, Lorena, Sánchez‐Pérez, José R.
• Format: Article
• Language: English
• Subjects: Acuity; Cerebrospinal fluid; Decompression; Decompression, Surgical; Diuretics; endoscopic optic nerve decompression; Endoscopy; Headache; Humans; Hypertension; idiopathic intracranial hypertension; nerve sheath fenestration; Optic nerve; Optic Nerve - surgery; papilledema; Patients; pseudotumor cerebri; Pseudotumor Cerebri - surgery; Shunts; Steroid hormones; Swelling; Treatment Outcome; Visual field
• ISSN: 2042-6976; 2042-6984
• DOI: 10.1002/alr.21927

Background The conventional treatment for idiopathic intracranial hypertension involves weight loss, steroids, diuretics, and/or serial lumbar punctures; however, if the symptoms persist or worsen, surgical intervention is recommended. Surgical options include cerebrospinal fluid diversion procedures, such as ventriculoperitoneal and lumboperitoneal shunts, and optic nerve decompression with nerve sheath fenestration. The latter can be carried out using an endoscopic approach, but the outcomes of this technique have not been firmly established. Methods This systematic review examined the outcomes of performing endoscopic optic nerve decompression (EOND) in patients with idiopathic intracranial hypertension (IIH). Six studies were included for a total of 34 patients. Results The patients presented with visual field disturbances (32 of 32 [100%]), visual acuity disruptions (33 of 34 [97.1%]), papilledema (26 of 34 [76.5%]), and persistent headache (30 of 33 [90.1%]). The mean duration of symptoms ranged from 7 to 32 months. Overall, the patients showed post‐EOND improvement in signs and symptoms associated with IIH, specifically visual field deficits (93.8%), visual acuity (85.3%), papilledema (81.4%), and headaches (81.8%). Interestingly, 11 cases showed postoperative improvement in their symptoms with bony decompression of the optic canal alone, without nerve sheath fenestration. There were no major adverse events or complications reported with this approach. Conclusion EOND appears to be a promising and safe surgical alternative for patients with IIH who fail to respond to medical treatment. Further studies are needed before we can attest to the clinical validity of this procedure.